Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Drug Ads
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new guidelines, which have been over 15 years in the making, are designed to end industry practices that downplay or distract viewers from risk information.
Why the FDA Wants TV Drug Ads to Use Simpler Words and Lose the Distractions
Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the Trump administration readies an offensive against big pharma.
FDA implements new rules for drug ads
The U.S. Food and Drug Administration (FDA) has implemented new rules for TV drug ads to make them clearer and more direct in explaining medication risks and side effects.
New FDA Rules for TV Drug Ads: Simpler Language and No Distractions
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when explaining their medications' risks and side effects.
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers from knowing risk information about drugs.
FDA puts new restrictions on TV ads for drugs
The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon.
FDA, RFK Jr and Big Pharma
RFK Jr. vow to purge FDA sets up collision with Big Pharma
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products.
RFK Jr. pick sparks FDA concerns
Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.
Analysis-RFK Jr vow to purge FDA sets up collision with Big Pharma
Robert F. Kennedy Jr. vowed to purge the U.S. Food and Drug Administration shortly before being chosen as President-elect Donald Trump's nominee for health secretary. Any changes he wants to make will come up against a pharmaceutical industry that pays much of the regulator's bills.
Food Safety News
3h
FDA doubles down on import enforcement for mycotoxins, heavy metals and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
8h
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
6h
on MSN
The FDA Initiated a Class III Recall on More Than 150,000 Bottles of Water
The product tested positive for Coliform, which are "considered indicators of fecal contamination and, thus, pathogenic ...
Food Safety News
3h
FDA closes active investigation into deadly outbreak linked to ‘mushroom’ edibles
The FDA’s investigation into a deadly outbreak of illnesses traced to Diamond Shruumz edible microdosing products has been switched from active to ...
STAT
21h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
17h
McDonald's Onion Recall Update as FDA Sets Highest Risk Level
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
federalnewsnetwork.com
1d
FDA sees high vacancy rates for drug manufacturer inspectors
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
Monthly Prescribing Reference
8h
FDA to Review Resubmitted Dupilumab sBLA for Chronic Spontaneous Urticaria
The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.
CCHR Int
7h
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback